• No results found

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TRICLOSAN IN DENTAL FORMULATIONS

N/A
N/A
Protected

Academic year: 2020

Share "ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TRICLOSAN IN DENTAL FORMULATIONS"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

FIG 1: STRUCTURE OF TRICLOSAN
FIG. 4: CALIBRATION CURVE OF TRICLOSAN
TABLE 5: ASSAY RESULTS OF TRICLOSAN Formulations Drug Amount of drug labeled
TABLE 10: RUGGEDNESS CONCENTRATION PREPARED BY DIFFERENT ANALYST Ruggedness Analyst -1 Analyst -2
+2

References

Related documents

AGDL: Agglomerative clustering on a directed graph; AGMFit: Affiliation graph model fitting; CD: Community discovery; CDlib: Community discovery library; CDTB: Community

Because there is no ground truth published for overlapping com- munities in the whole network and we have demonstrated that our communities well represent the ground truth, we make

We used a thematic analysis [50] to summarize respondents ’ major thoughts and concerns about post-mortem needle biop- sies, including acceptable motivations for conducting

From Figure 9(a) we can see that most of the ASes in this group used the SMTP protocol to send spam, but the few Autonomous Systems using SOCKS and HTTP protocols sent more than

BATs imbued with HTCFs collected from glaucomatous patients exhibited a greater proportion of myo fi - broblasts as well as increased collagen contraction/remodeling compared to

The combination of TDN and cefepime were found to show synergistic activity against all tested isolates followed by ceftriaxone (96%), amikacin (88%), and cipro fl oxacin

In comparison to a shorter duration of EA, the increase of cold threshold temperatures with sustained warm threshold temperature elevation and the lingering analgesic effect after

Fig.15 shows that power consumption across output load capacitance is highest for existing SAFF, while it is least for proposed SAFF and almost comparable with modified design..